Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 130–131 (2006)Cite this article

boxed-textBiswas M et al. (2005) Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin Endocrinol 63: 26–31

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vance ML et al. (1984) Drugs five years later. Bromocriptine. Ann Intern Med 100: 78–91

    Article  CAS  Google Scholar 

  2. Verhelst J et al. (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84: 2518–2522

    Article  CAS  Google Scholar 

  3. Zarate A et al. (1983) Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine. Acta Endocrinol (Copenh) 104: 139–142

    Article  CAS  Google Scholar 

  4. Passos VQ et al. (2002) Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab 87: 3578–3582

    Article  CAS  Google Scholar 

  5. Colao A et al. (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349: 2023–2033

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Ian Newman, Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Endocrinology and Chief of the Division of Endocrinology and Metabolism, Neuroendocrine Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil

    Marcello D Bronstein

Authors
  1. Marcello D Bronstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcello D Bronstein.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bronstein, M. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. Nat Rev Endocrinol 2, 130–131 (2006). https://doi.org/10.1038/ncpendmet0135

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0135

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing